{"DataElement":{"publicId":"6953015","version":"1","preferredName":"Malignant Neoplasm Pathologic N Stage Category","preferredDefinition":"Information related to the pathologic N (nodal) stage for a malignant neoplasm.","longName":"6951579v1.0:6953008v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"6951579","version":"1","preferredName":"Malignant Neoplasm Pathologic N Category","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"2186369v1.0:2428379v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428379","version":"1","preferredName":"Pathologic N Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25610:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-084E-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93CD3CDE-49AA-731B-E053-F662850AB38C","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"MORENOC","dateModified":"2020-03-05","changeDescription":"3/5/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6953008","version":"1","preferredName":"Malignant Neoplasm Pathologic N Stage","preferredDefinition":"The pathologic N (nodal) stage for a malignant neoplasm.","longName":"6953008v1.0","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pN0(i-)","valueDescription":"Pathologic N0 (i-) Stage Finding","ValueMeaning":{"publicId":"6953010","version":"1","preferredName":"Pathologic N0 (i-) Stage Finding","longName":"6953010","preferredDefinition":"Caused by or altered by or manifesting disease or pathology.: A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically, and immunohistochemistry is negative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"pN0 (i-) TNM Finding","conceptCode":"C95921","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically, and immunohistochemistry is negative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93D99650-735B-4E64-E053-F662850ABA78","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93D99650-7374-4E64-E053-F662850ABA78","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","deletedIndicator":"No"},{"value":"pN0(i+)","valueDescription":"Pathologic N0 (i+) Stage Finding","ValueMeaning":{"publicId":"6953009","version":"1","preferredName":"Pathologic N0 (i+) Stage Finding","longName":"6953009","preferredDefinition":"Caused by or altered by or manifesting disease or pathology.: A regional lymph node TNM finding indicating that there are malignant cells in regional lymph node(s) no greater than 0.2 mm and are detected by hematoxylin and eosin stain or immunohistochemistry.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"pN0 (i+) TNM Finding","conceptCode":"C95922","definition":"A regional lymph node TNM finding indicating that there are malignant cells in regional lymph node(s) no greater than 0.2 mm and are detected by hematoxylin and eosin stain or immunohistochemistry.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93D99650-7335-4E64-E053-F662850ABA78","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93D99650-734E-4E64-E053-F662850ABA78","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","deletedIndicator":"No"},{"value":"pN1mi","valueDescription":"Pathologic N1mi Stage Finding","ValueMeaning":{"publicId":"6953011","version":"1","preferredName":"Pathologic N1mi Stage Finding","longName":"6953011","preferredDefinition":"Caused by or altered by or manifesting disease or pathology.: A regional lymph node TNM finding indicating the presence of micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N1mi TNM Finding","conceptCode":"C95955","definition":"A regional lymph node TNM finding indicating the presence of micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93D99650-7381-4E64-E053-F662850ABA78","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93D99650-739A-4E64-E053-F662850ABA78","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","deletedIndicator":"No"},{"value":"pNX","valueDescription":"Pathologic NX Stage Finding","ValueMeaning":{"publicId":"6953012","version":"1","preferredName":"Pathologic NX Stage Finding","longName":"6953012","preferredDefinition":"Caused by or altered by or manifesting disease or pathology.: A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93D99650-73A7-4E64-E053-F662850ABA78","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93D99650-73C0-4E64-E053-F662850ABA78","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","deletedIndicator":"No"},{"value":"pN0","valueDescription":"PN0 Stage Finding","ValueMeaning":{"publicId":"5529011","version":"1","preferredName":"PN0 Stage Finding","longName":"5529011","preferredDefinition":"No morphologic evidence of regional lymph node metastasis by routine histologic staining, in accordance with TNM classification system guidelines.","context":"TEST","contextVersion":"1","Concepts":[{"longName":"pN0 TNM Finding","conceptCode":"C48745","definition":"No morphologic evidence of regional lymph node metastasis by routine histologic staining, in accordance with TNM classification system guidelines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F500E39-00B6-1AEF-E053-F662850ADCC7","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93D99650-73D4-4E64-E053-F662850ABA78","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","deletedIndicator":"No"},{"value":"pN1","valueDescription":"Pathologic N1 Stage Finding","ValueMeaning":{"publicId":"6953013","version":"1","preferredName":"Pathologic N1 Stage Finding","longName":"6953013","preferredDefinition":"Caused by or altered by or manifesting disease or pathology.: A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N1 TNM Finding","conceptCode":"C48706","definition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93D99650-73E2-4E64-E053-F662850ABA78","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93D99650-73FB-4E64-E053-F662850ABA78","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","deletedIndicator":"No"},{"value":"pN2","valueDescription":"pN2 Stage Finding","ValueMeaning":{"publicId":"2839737","version":"1","preferredName":"pN2 Stage Finding","longName":"2839737v1.00","preferredDefinition":"A pathologic regional lymph nodes TNM finding. The definition of pN2 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pN2 finding is defined as follows: cancer with metastases in 4 to 9 axillary lymph nodes, or metastases in clinically detected internal mammary lymph nodes in the absence of axillary lymph node metastases. \"Clinically detected\" is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination and having characteristics highly suspicious for malignancy or a presumed pathologic macrometastasis based on fine needle aspiration biopsy with cytologic examination; for colorectal cancer, pN2 stage finding is defined as follows: cancer with metastasis in four or more regional lymph nodes. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pN2 TNM Finding","conceptCode":"C48750","definition":"A pathologic regional lymph nodes TNM finding. The definition of pN2 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pN2 finding is defined as follows: cancer with metastases in 4 to 9 axillary lymph nodes, or metastases in clinically detected internal mammary lymph nodes in the absence of axillary lymph node metastases. \"Clinically detected\" is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination and having characteristics highly suspicious for malignancy or a presumed pathologic macrometastasis based on fine needle aspiration biopsy with cytologic examination; for colorectal cancer, pN2 stage finding is defined as follows: cancer with metastasis in four or more regional lymph nodes. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6334274B-07A5-2ECE-E040-BB89AD432AD5","latestVersionIndicator":"Yes","beginDate":"2009-02-18","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-18","modifiedBy":"KUMMEROA","dateModified":"2023-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93D99650-740F-4E64-E053-F662850ABA78","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","deletedIndicator":"No"},{"value":"pN3","valueDescription":"Pathologic N3 Stage Finding","ValueMeaning":{"publicId":"6953014","version":"1","preferredName":"Pathologic N3 Stage Finding","longName":"6953014","preferredDefinition":"Caused by or altered by or manifesting disease or pathology.: A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N3 TNM Finding","conceptCode":"C48714","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93D99650-741D-4E64-E053-F662850ABA78","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93D99650-7436-4E64-E053-F662850ABA78","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"ONEDATA","dateModified":"2019-10-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93D99650-731D-4E64-E053-F662850ABA78","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"KUMMEROA","dateModified":"2023-08-14","changeDescription":"3/5/2020: CM Released as part of draft content review","administrativeNotes":"2023.8.14 Updated PV def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"N stage","type":"Preferred Question Text","description":"N stage","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93D93096-3D50-4E54-E053-F662850A3C34","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-01","modifiedBy":"MORENOC","dateModified":"2020-03-05","changeDescription":"3/5/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}